{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:49:21Z","timestamp":1793677761812,"version":"4.5.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"publisher","award":["14\/TPG\/1-15"],"award-info":[{"award-number":["14\/TPG\/1-15"]}],"id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["14\/TPG\/1-15"],"award-info":[{"award-number":["14\/TPG\/1-15"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001102","name":"Cancer Council New South Wales","doi-asserted-by":"publisher","award":["14\/TPG\/1-15"],"award-info":[{"award-number":["14\/TPG\/1-15"]}],"id":[{"id":"10.13039\/501100001102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","award":["14\/TPG\/1-15"],"award-info":[{"award-number":["14\/TPG\/1-15"]}],"id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ygyno.2021.06.028","type":"journal-article","created":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T08:32:04Z","timestamp":1625473924000},"page":"720-727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer"],"prefix":"10.1016","volume":"162","author":[{"given":"Bonnita","family":"Werner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Yuwono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Duggan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivatharsny","family":"Srirangan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Provan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"DeFazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeh Chen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Warton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2021.06.028_bb0005","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.06.028_bb0010","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2021.06.028_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41416-020-0875-x","article-title":"The untapped potential of ascites in ovarian cancer research and treatment","volume":"123","author":"Ford","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.06.028_bb0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5306\/wjco.v9.i8.167","article-title":"Malignant peritoneal effusion acting as a tumor environment in ovarian cancer progression: impact and significance","volume":"9","author":"Piche","year":"2018","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2021.06.028_bb0025","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ygyno.2021.06.028_bb0030","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4143\/crt.2019.700","article-title":"Clinical implications of circulating tumor DNA from ascites and serial plasma in ovarian Cancer","volume":"52","author":"Han","year":"2020","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.ygyno.2021.06.028_bb0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/15384047.2018.1504720","article-title":"Next-generation sequencing reveals mutational accordance between cell-free DNA from plasma, malignant pleural effusion and ascites and directs targeted therapy in a gastric cancer patient","volume":"20","author":"Zhou","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ygyno.2021.06.028_bb0040","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1158\/1535-7163.MCT-16-0436","article-title":"Cell-free DNA from ascites and pleural effusions: molecular insights into genomic aberrations and disease biology","volume":"16","author":"Husain","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ygyno.2021.06.028_bb0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/gcc.22517","article-title":"A field guide for cancer diagnostics using cell-free DNA: from principles to practice and clinical applications","volume":"57","author":"Volckmar","year":"2018","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.ygyno.2021.06.028_bb0050","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cancergen.2018.02.004","article-title":"Comparison of 4 commercial kits for the extraction of circulating DNA from plasma","volume":"228-229","author":"Warton","year":"2018","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ygyno.2021.06.028_bb0055","doi-asserted-by":"crossref","first-page":"112727","DOI":"10.18632\/oncotarget.22559","article-title":"Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis","volume":"8","author":"Henry","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2021.06.028_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224338","article-title":"Circulating cell-free DNA from plasma undergoes less fragmentation during bisulfite treatment than genomic DNA due to low molecular weight","volume":"14","author":"Werner","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2021.06.028_bb0065","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/bioinformatics\/bty790","article-title":"smCounter2: an accurate low-frequency variant caller for targeted sequencing data with unique molecular identifiers","volume":"35","author":"Xu","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ygyno.2021.06.028_bb0070","first-page":"1659","article-title":"DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells","volume":"61","author":"Jahr","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2021.06.028_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/0471143030.cb0322s30","article-title":"Isolation and characterization of exosomes from cell culture supernatants and biological fluids","author":"Thery","year":"2006","journal-title":"Curr. Protoc. Cell Biol."},{"key":"10.1016\/j.ygyno.2021.06.028_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046858","article-title":"Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors","volume":"7","author":"Latifi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2021.06.028_bb0085","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1084\/jem.20180765","article-title":"Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer","volume":"216","author":"Gao","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ygyno.2021.06.028_bb0090","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1038\/s41388-018-0317-x","article-title":"Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer","volume":"37","author":"Al Habyan","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2021.06.028_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028141","article-title":"Genome-scale screen for DNA methylation-based detection markers for ovarian cancer","volume":"6","author":"Campan","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2021.06.028_bb0100","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ygyno.2011.11.026","article-title":"Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer","volume":"124","author":"Montavon","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.06.028_bb0105","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/1471-2164-15-476","article-title":"Methylation-capture and next-generation sequencing of free circulating DNA from human plasma","volume":"15","author":"Warton","year":"2014","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ygyno.2021.06.028_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166354","article-title":"Performance of Streck cfDNA blood collection tubes for liquid biopsy testing","volume":"11","author":"Medina Diaz","year":"2016","journal-title":"PLoS One"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821005242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821005242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:59:00Z","timestamp":1758772740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821005242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0090825821005242"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.06.028","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.06.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}